Perfuse Therapeutics
Pre-clinicalPerfuse Therapeutics is developing a product to improve blood flow to the retina, the most metabolically demanding tissue in the human body.
Founded
2020
Focus
CardiovascularDrug Delivery
About
Perfuse Therapeutics is developing a product to improve blood flow to the retina, the most metabolically demanding tissue in the human body.
Funding History
2Total raised: $21.5M
Series A$18MUndisclosedSep 15, 2023
Seed$3.5MUndisclosedMar 15, 2022
Company Info
TypePrivate
Founded2020
LocationCambridge, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile